TATEISHI Kazunari

Academic Assembly School of Medicine and Health Sciences Institute of Medicine

Shinshu University Hospital Respirology & Infectious Disease & Allergology 

Senior Assistant Professor 

Researcher Information

Degree

  • 医学博士, 信州大学

Field Of Study

  • Respiratory medicine, Lung cancer
Research activity information

Paper

  • Nonfibrotic Hypersensitivity Pneumonitis Complicated by Chronic Progressive Pulmonary Aspergillosis : A Case Report
    Kanayama, Risa; Wada, Yosuke; Tateishi, Kazunari; Kitaguchi, Yoshiaki; Ushiki, Atsuhito; Hanaoka, Masayuki
    The Shinshu Medical Journal, 71(4), 235-240, Aug. 2023リポジトリ電子ジャーナル
  • Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
    Araki T, Kanda S, Komatsu M, Sonehara K, Tateishi K, Takada M, Kato A, Yamamoto M, Nishie K, Hama M, Agatsuma T, Kakizaki Y, Yoshiike F, Matsuo A, Chiaki T, Samizo K, Takagi Y, Yamaura M, Hanaoka M, Koizumi T.
    Transl Lung Cancer Res, 2023電子ジャーナル
  • Predictive Factors Associated with Long-Term Response to Combination Immunotherapy in Patients with Untreated Advanced Non-Small-Cell Lung Cancer: A Multicenter Retrospective Study
    Sonehara K, Ozawa R, Hama M, Nozawa S, Agatsuma T, Nishie K, Kato A, Matsuo A, Araki T, Komatsu M, Tateishi K, Hanaoka M.
    ONCOLOGY, 2023電子ジャーナル
  • C-PLAN index as a prognostic factor for patients with previously untreated advanced non-small cell lung cancer who received combination immunotherapy: A multicenter retrospective study
    Sonehara K, Ozawa R, Hama M, Nozawa S, Agatsuma T, Nishie K, Kato A, Matsuo A, Araki T, Komatsu M, Tateishi K, Hanaoka M.
    Thorac Cancer, 2023電子ジャーナル
  • Usual Interstitial Pneumonia Pattern Interstitial Lung Disease Developed in a Patient with IgG4-related Chronic Sclerosing Sialadenitis
    Yamamoto H, Komatsu M, Sonehara K, Ikuyama Y, Urushihata K, Tateishi K, Kitaguchi Y, Ushuiki A, Asaka S, Uehara T, Kawakami S, Mori K, Hamanaka K, Nishie K, Hebisawa A, Hanaoka M.
    Intern Med, 2022電子ジャーナル
  • Prospective assessment using (18)F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer
    Yamaguchi O, Kaira K, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Tateishi K, Kasahara N, Higuchi T, Hashimoto K, Shinomiya S, Miura Y, Shiono A, Mouri A, Imai H, Iizuka K, Ishizuka T, Minato K, Suda S, Kagamu H, Mori K, Kuji I, Seki N.
    Sci Rep, 2022電子ジャーナル
  • Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression
    Ikezawa Y, Mizugaki H, Morita R, Tateishi K, Yokoo K, Sumi T, Kikuchi H, Kitamura Y, Nakamura A, Kobayashi M, Aso M, Kimura N, Yoshiike F, Furuta M, Tanaka H, Sekikawa M, Hachiya T, Nakamura K, Shimokawa M, Oizumi S.
    Cancer Sci, 2022電子ジャーナル
  • Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy
    Araki T, Tateishi K, Komatsu M, Sonehara K, Kanda S, Hanaoka M, Koizumi T.
    Thorac Cancer, 2022電子ジャーナル
  • Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy
    Araki T, Tateishi K, Komatsu M, Sonehara K, Wasamoto S, Koyama S, Yoshiike F, Hama M, Nishie K, Kondo D, Agatsuma T, Kato A, Takata M, Kanda S, Hanaoka M, Koizumi T.
    Thorac Cancer, 2022電子ジャーナル
  • Predictive Factors Correlated with the Development of Immune-Related Adverse Events in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Sonehara K, Tateishi K, Araki T, Komatsu M, Akahane J, Yamamoto H, Hanaoka M.
    Cancer Manag Res, 2022電子ジャーナル
  • Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy
    Sonehara, Kei; Tateishi, Kazunari; Araki, Taisuke; Komatsu, Masamichi; Yamamoto, Hiroshi; Hanaoka, Masayuki;
    Thoracic cancer, 12(9), 1366-1372, May 2021電子ジャーナル
  • The Role of Immune-Related Adverse Events in Prognosis and Efficacy Prediction for Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: A Retrospective Clinical Analysis
    Sonehara, Kei; Tateishi, Kazunari; Araki, Taisuke; Komatsu, Masamichi; Yamamoto, Hiroshi; Koizumi, Tomonobu; Hanaoka, Masayuki;
    ONCOLOGY, 99(5), 271-279, Apr. 2021電子ジャーナル
  • Clinical utility of the C-reactive protein:albumin ratio in non-small cell lung cancer patients treated with nivolumab
    Araki, Taisuke; Tateishi, Kazunari; Sonehara, Kei; Hirota, Shuko; Komatsu, Masamichi; Yamamoto, Manabu; Kanda, Shintaro; Kuraishi, Hiroshi; Hanaoka, Masayuki; Koizumi, Tomonobu;
    Thoracic cancer, 12(5), 603-612, Mar. 2021電子ジャーナル
  • Prognostic implication of erector spinae muscles in non-small-cell lung cancer patients treated with immuno-oncology combinatorial chemotherapy
    Araki T, Kitaguchi Y, Suzuki Y, Komatsu M, Sonehara K, Wada Y, Tateishi K, Hanaoka M.
    Thorac Cancer, 2021電子ジャーナル
  • A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency
    Sonehara K, Tateishi K, Hirabayashi T, Araki T, Ikuyama Y, Machida R, Hanaoka M.
    Case Rep Oncol, 2021電子ジャーナル
  • Pembrolizumab-Induced Adrenal Insufficiency in Patients with Untreated Advanced Non-Small Cell Lung Cancer: A Case Series
    Sonehara K, Tateishi K, Araki T, Komatsu M, Akahane J, Yamamoto H, Hanaoka M.
    Case Rep Oncol, 2021電子ジャーナル
  • Thymic epithelial tumor with superior vena cava syndrome diagnosed by percutaneous endovascular tumor biopsy: A report of two cases
    Araki T, Kobayashi T, Kobayashi S, Sonehara K, Tateishi K, Kanda S, Hanaoka M, Koizumi T.
    Respir Investig, 2021電子ジャーナル
  • Prognostic factors for patients with metastatic or recurrent thymic carcinoma receiving palliative-intent chemotherapy
    Okuma, Yusuke; Ko, Ryo; Shukuya, Takehito; Tateishi, Kazunari; Imai, Hisao; Iwasawa, Shunichiro; Miyauchi, Eisaku; Kojima, Tetsuya; Fujita, Yuka; Hino, Toshihiko; Yamanda, Shinsuke; Suzuki, Toshiro; Fukuizumi, Aya; Sakakibara, Tomohiro; Harada, Toshiyuki; Morita, Satoshi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Takahashi, Kazuhisa; North East Japan Study Grp;
    Lung Cancer, 148, 122-128, Oct. 2020電子ジャーナル
  • Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study
    Tateishi, Kazunari; Ko, Ryo; Shukuya, Takehito; Okuma, Yusuke; Watanabe, Satoshi; Kuyama, Shoichi; Murase, Kyoko; Tsukita, Yoko; Ashinuma, Hironori; Nakagawa, Taku; Uematsu, Kazutsugu; Nakao, Mika; Mori, Yoshiaki; Kaira, Kyoichi; Mouri, Atsuto; Miyabayashi, Takao; Sakashita, Hiroyuki; Matsumoto, Yoko; Tanigawa, Tomoyuki; Koizumi, Tomonobu; Morita, Satoshi; Kobayashi, Kunihiko; Nukiwa, Toshihiro; Takahashi, Kazuhisa; North East Japan Study Grp;
    Oncologist, 25(4), E668-E678, Apr. 2020WebofScience電子ジャーナル
  • Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report
    Ikuyama Y, Wada Y, Tateishi K, Kitaguchi Y, Yasuo M, Ushiki A, Urushihata K, Yamamoto H, Kamijo H, Mita A, Imamura H, Hanaoka M.
    Respir Med Case Rep, 2020電子ジャーナル
  • Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer
    Fukushima, Toshirou; Wakatsuki, Yuuki; Kobayashi, Takashi; Sonehara, Kei; Tateishi, Kazunari; Yamamoto, Manabu; Masubuchi, Takeshi; Yoshiike, Fumiaki; Hirai, Kazuya; Hachiya, Tsutomu; Koizumi, Tomonobu;
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 81(6), 1043-1050, Jun. 2018WebofScience電子ジャーナル
  • Correlation of early PET findings with tumor response to molecular targeted agents in patients with advanced driver-mutated non-small cell lung cancer.
    Koizumi T, Fukushima T, Gomi D, Kobayashi T, Sekiguchi N, Mamiya K, Tateishi K, Katou A, Oguchi K.
    Med Oncol, 34(10), 169, Sep. 2017電子ジャーナル
  • Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography.
    Ozawa Y, Yamamoto H, Yasuo M, Takahashi H, Tateishi K, Ushiki A, Kawakami S, Fujinaga Y, Asaka S, Sano K, Takayama H, Imamura H, Hanaoka M.
    Respir Investig, 55(2), 176-180, Mar. 2017電子ジャーナル
  • Clinical analysis of patients treated with afatinib for advanced non-small cell lung cancer: A Nagano Lung Cancer Research Group observational study.
    Wada Y, Koyama S, Kuraishi H, Miyahara T, Yoshiike F, Agatsuma T, Yamamoto R, Ono Y, Suzuki T, Hachiya T, Gomi D, Tateishi K, Hanaoka M, Koizumi T.
    Respir Investig, 54(6), 462-467, Nov. 2016電子ジャーナル
  • A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT.
    Kato A, Yamamoto H, Ikeda M, Tateishi K, Ushiki A, Yasuo M, Kawakami S, Asaka S, Oguchi K, Hanaoka M.
    Respir Med Case Rep, 19, 49-52, Jul. 2016電子ジャーナル
  • Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study.
    Booka E, Imamura CK, Takeuchi H, Hamamoto Y, Gomi D, Mizukami T, Ichiyama T, Tateishi K, Takahashi T, Kawakubo H, Soejima K, Boku N, Tanigawara Y, Kitagawa Y.
    Gastric Cancer, 19(3), 876-86, Jul. 2016電子ジャーナル
  • Nivolumab-induced organizing pneumonia in a melanoma patient
    Sano, Tasuku; Uhara, Hisashi; Mikoshiba, Yasutomo; Kobayashi, Aya; Uchiyama, Ryuhei; Tateishi, Kazunari; Yamamoto, Hiroshi; Okuyama, Ryuhei;
    Japanese journal of clinical oncology, 46(3), 270-272, Mar. 2016WebofScience電子ジャーナル
  • Clinical outcomes in patients with small cell lung cancer in a single institute: Comparative analysis of radiographic screening with symptom-prompted patients
    Fukushima, Toshirou; Tateishi, Kazunari; Hanaoka, Masayuki; Koizumi, Tomonobu;
    Lung Cancer, 88(1), 48-51, Apr. 2015WebofScience電子ジャーナル
  • Development of dosing recommendation of S-1 for patients with impaired renal function by prospective pharmacokinetic study.
    Booka, Eisuke; Imamura, Chiyo K.; Hamamoto, Yasuo; Mizukami, Takuro; Gomi, Daisuke; Ichiyama, Takashi; Tateishi, Kazunari; Takahashi, Tsunehiro; Kawakubo, Hirofumi; Soejima, Kenzo; Takeuchi, Hiroya; Boku, Narikazu; Tanigawara, Yusuke; Kitagawa, Yuko;
    JOURNAL OF CLINICAL ONCOLOGY, 33(15), 2015WebofScience
  • Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer
    Komatsu, Masamichi; Yasuo, Masanori; Kobayashi, Nobumitsu; Tateishi, Kazunari; Ushiki, Atsuhito; Urushihata, Kazuhisa; Yamamoto, Hiroshi; Hanaoka, Masayuki; Matoba, Hisanori; Honda, Takayuki; Ichikawa, Kosuke;
    INTERNAL MEDICINE, 54(16), 2045-2049, 2015WebofScience電子ジャーナル
  • Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer
    Komatsu, Masamichi; Yasuo, Masanori; Kobayashi, Nobumitsu; Tateishi, Kazunari; Ushiki, Atsuhito; Urushihata, Kazuhisa; Yamamoto, Hiroshi; Hanaoka, Masayuki; Matoba, Hisanori; Honda, Takayuki; Ichikawa, Kosuke;
    INTERNAL MEDICINE, 54(16), 2045-2049, 2015WebofScience電子ジャーナル
  • Late-onset Rejection of a Unilateral Donor Lung with Vascular C4d Deposition in Bilateral Living-donor Lobar Lung Transplantation: An Autopsy Case Report
    Yamamoto, Hiroshi; Yoshida, Kazuo; Koizumi, Tomonobu; Tokoro, Yayoi; Fukushima, Toshiro; Tateishi, Kazunari; Ushiki, Atsuhito; Yokoyama, Toshiki; Yasuo, Masanori; Urushihata, Kazuhisa; Hanaoka, Masayuki; Shingu, Kunihiko; Shimojo, Hisashi; Kanno, Hiroyuki; Yoshizawa, Akihiko; Kawakami, Satoshi; Miyagawa-Hayashino, Aya; Date, Hiroshi; Kubo, Keishi;
    INTERNAL MEDICINE, 53(15), 1645-1650, 2014WebofScience電子ジャーナル
  • A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN LUNG CANCER PATIENTS
    Fujita, Masaki; Takayama, Koichi; Ono, Akira; Takeda, Koji; Ohira, Tatsuo; Isobe, Hiroshi; Ebi, Noriyuki; Tateishi, Kazunari; Yamamoto, Nobuyuki; Nakanishi, Yoichi; Tamura, Kazuo;
    JOURNAL OF THORACIC ONCOLOGY, 8, S406-S406, Nov. 2013WebofScience
  • Clinical characteristics and outcomes of patients with small cell lung cancer detected by CT screening
    Fukushima, T; Tateishi, K; Yamamoto, H; Hanaoka, M; Kubo, K; Koizumi, T
    MEDICAL ONCOLOGY, 30(3), 623, Sep. 2013WebofScienceリポジトリ電子ジャーナル
  • Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group Study
    Tateishi K, Ichiyama T, Hirai K, Agatsuma T, Koyama S, Hachiya T, Morozumi N, Shiina T, Koizumi T.
    MEDICAL ONCOLOGY, 30, 450, 13 Jan. 2013
  • Primary malignant sarcomatoid mesothelioma in the pericardium
    Tateishi Kazunari,Ikeda Mariko,Yokoyama Toshiki,Urushihata Kazuhisa,Yamamoto Hiroshi,Hanaoka Masayuki,Kubo Keishi,Sakai Yasuhiro,Nakayama Jun,Koizumi Tomonobu
    INTERNAL MEDICINE, 52(2), 249-253, 2013WebofScienceリポジトリ電子ジャーナル
  • 呼吸器診療での肺機能検査の必要性とその活用(11)疾患編 肺血管障害
    立石 一成,花岡 正幸,久保 惠嗣
    呼吸と循環, 60(11), 1144-1148, Nov. 2012
  • CLINICAL UTILITY OF CT-GUIDED BRONCHOSCOPY RADIOFREQUENCY ABLATION AS A NOVEL INTERVENTION THERAPY FOR LUNG CANCER
    Koizumi, Tomonobu; Tanabe, Tuyoshi; Tsushima, Kenji; Tateishi, Kazunari; Fukushima, Toshiro; Hama, M.; Horiuchi, M.; Kobayashi, N.; Ikegami, K.; Tokoro, Y.; Ushiki, A.; Yokoyama, T.; Kobayashi, T.; Yasuo, M.; Urushihata, K.; Yamamoto, H.; Hanaoka, M.; Kubo, K.;
    JOURNAL OF THORACIC ONCOLOGY, 7(11), S447-S447, Nov. 2012WebofScience
  • 診断および治療経過を観察できた肺腺癌小腸転移の1例
    立石 一成,小泉 知展,漆畑 一寿,山本 洋,花岡 正幸,久保 惠嗣
    肺癌, 52(3), 310-314, 2012

Lectures, oral presentations, etc.

  • MS66. PD-L1高発現非小細胞肺癌患者におけるペムブロリズマブおよびプラチナ製剤併用療法 + ペムブロリズマブの多施設共同観察研究 (第2報)
  • PP364. 進行非小細胞肺癌における免疫チェックポイント阻害薬の長期奏効に関わる臨床的検討
  • PP482. 気管支鏡検体におけるOncomine(TM) Dx Target Testによる解析の後方視的検討
  • PP651. 進行非小細胞肺癌における複合免疫療法の臨床的有用性を評価した多施設共同後方視的研究
  • P8-4. PS2の進行・再発非小細胞肺癌における複合免疫療法の実際
  • P10-5. 75歳以上未治療進行・再発非小細胞肺癌における複合免疫療法の有効性・安全性の検討
  • P52-2. 初回オシメルチニブ耐性後のEGFR TKI再投与に関する臨床的検討
  • MS55. 進行非小細胞肺癌におけるPD-1阻害剤の早期効果予測としてのFDG-PET
  • MS102. PD-L1高発現NSCLC患者におけるペムブロリズマブおよびプラチナ製剤併用療法+ペムブロリズマブの多施設共同観察研究
  • PP299. 複合免疫療法を受けた進行非小細胞肺癌患者における脊柱起立筋面積と予後との関連
  • PP557. 免疫療法を施行された非小細胞肺癌症例の免疫関連有害事象の発症予測因子としてのLung immune prognostic indexの有用性
  • PP565. 免疫関連有害事象としての副腎機能不全の臨床的特徴に関する後方視的検討
  • O26-2. 進行非小細胞肺癌におけるPD-1阻害剤の早期効果予測としてのFDG-PET
  • 4. ALK陽性肺紡錘細胞癌の1例
  • PD11-1-2. 進行・再発非小細胞肺癌の1次治療における免疫チェックポイント阻害薬の長期奏効に関わる臨床的背景の検討
  • OP528. 免疫療法が施行された非小細胞肺癌症例の予後および治療効果予測における免疫関連有害事象の役割に関する後方視的な検討
  • O34-7. PD-L1高発現非小細胞肺癌患者におけるPembrolizumab, プラチナ併用療法+Pembrolizumabの多施設共同観察研究
  • P3-3-1. 免疫治療を施行された非小細胞肺癌における予後予測因子としてのGeriatric Nutritional Risk Indexの有用性
  • P1-9-148 (C). 小細胞肺癌に対する予後予測因子としてのlung immune prognostic indexの有用性
  • P1-10-175 (E). 経静脈的腫瘍生検で診断しえた上大静脈症候群合併胸腺癌の2例
  • PP193. 非小細胞肺癌に対するNivolumabおよびPembrolizumabによる治療の後方視的解析
  • PP226. 間質性肺炎合併小細胞肺癌に対する化学療法の後方視的解析
  • PP383. 既治療非小細胞肺癌に対するRamucirumab, Docetaxel併用療法の治療成績
  • PP880. 中枢性尿崩症を併発した手術不能進行期胸腺癌の治療経験
  • P4-7. Osimertinibによる舌の色素沈着をきたした非小細胞肺癌の1例
  • P7-10. 進展型小細胞肺癌に対する予後予測因子としてのmodified Glasgow Prognostic Scoreの有用性